Zanosar (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Zanosar drug offered from Teva Parenteral Medicines, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: streptozocin
SUBSTANCE NAME: STREPTOZOCIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-12-03
END MARKETING DATE: 0000-00-00


Zanosar HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZanosar from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2003-12-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-4636_3ea01059-8c39-431c-a1c4-c03315b083e1
PRODUCT NDC: 0703-4636
APPLICATION NUMBER: NDA050577

Other STREPTOZOCIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Teva Parenteral Medicines, Inc.Zanosar